Skip to content

Pacific Biosciences of California PACB Other intangible assets—net

Other intangible assets—net at other companies

Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$144.89M-27.4%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$59.91M+294%
Illumina logo
IlluminaILMN
Revvity logo
RevvityRVTY
Agilent Technologies logo
Agilent TechnologiesA
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's other intangible assets—net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's other intangible assets—net?
Pacific Biosciences of California (PACB) reported other intangible assets—net of $14.1M in Q1 2026.
How has Pacific Biosciences of California's other intangible assets—net changed year-over-year?
Pacific Biosciences of California's other intangible assets—net decreased by 22.4% year-over-year, from $18.18M to $14.1M.
What is the long-term trend for Pacific Biosciences of California's other intangible assets—net?
Over 4 years (2021 to 2025), Pacific Biosciences of California's other intangible assets—net has grown at a -56.2% compound annual growth rate (CAGR), from $410.98M to $15.12M.
What does other intangible assets—net mean?
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.